Pfizer Inc., Eli Lilly & Co. and eight other large drugmakers will partner with the U.S. government in a $230 million effort to identify new approaches to treat Alzheimer’s, diabetes, lupus and arthritis.
Butamax Advanced Biofuels LLC asked the U.S. Patent and Trademark Office to reexamine a disputed patent owned by Gevo Inc., the U.S. biotechnology company backed by the oil refiner Total SA and the specialty chemicals maker Lanxess AG.
Descendants of Henrietta Lacks, a poor black tobacco farmer whose cells were taken without consent and used in 74,000 medical studies since the 1950s, will have a say over how that genomic data will be used.
Intellectual Ventures Management LLC, a patent-licensing firm that claims to own more than 30,000 patents and to have earned almost $2 billion in licensing fees, filed three patent-infringement suits against technology companies yesterday.
With a government shutdown upon us, it’s worth pondering this drama’s endgame. Does anyone seriously think Democrats in the Senate or the White House will abandon the president’s signature legislative accomplishment in order to appease a few dozen congressional Republicans with an appetite for hyperbole? Hands? Anyone? Didn’t think so.